Organigram (OGI) Stock Price, News & Analysis

Company Overview

Organigram Holdings Inc., through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Edison JOLTS, Tremblant, and Laurentian brands. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative-based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as consumer channels. The company was incorporated in 2010 and is headquartered in Toronto, Canada.

Key Stats

• Today's Range: $1.02 to $1.07
• 50-Day Range: $0.88 to $1.73
• 52-Week Range: $0.85 to $2.17
• Volume: 399,772 shs
• Average Volume: 768,827 shs
• Market Capitalization: $130.67 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Buy

Organigram Stock Analysis - MarketRank™

Organigram scored higher than 13% of companies evaluated by MarketBeat, and ranked 882nd out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Organigram.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Organigram are expected to grow in the coming year, from ($0.19) to ($0.06) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Organigram is -2.74, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Organigram is -2.74, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Organigram has a P/B Ratio of 0.57. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

7.34% of the float of Organigram has been sold short.

Short Interest Ratio / Days to Cover

Organigram has a short interest ratio ("days to cover") of 7.1.

Change versus previous month

Short interest in Organigram has recently increased by 17.83%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Organigram does not currently pay a dividend.

Dividend Growth

Organigram does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

7.34% of the float of Organigram has been sold short.

Short Interest Ratio / Days to Cover

Organigram has a short interest ratio ("days to cover") of 7.1.

Change versus previous month

Short interest in Organigram has recently increased by 17.83%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 4.0 / 5
• News Sentiment: 1.18

News Sentiment

Organigram has a news sentiment score of 1.18. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.79 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 3 news articles for Organigram this week, compared to 1 article on an average week.

Search Interest

5 people have searched for OGI on MarketBeat in the last 30 days. This is an increase of 400% compared to the previous 30 days.

MarketBeat Follows

6 people have added Organigram to their MarketBeat watchlist in the last 30 days. This is an increase of 500% compared to the previous 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Organigram insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 0.09% of the stock of Organigram is held by insiders.

Percentage Held by Institutions

Only 34.63% of the stock of Organigram is held by institutions.

OGI Stock Analysis - Frequently Asked Questions

How have OGI shares performed this year?

Organigram's stock was trading at $1.61 at the beginning of the year. Since then, OGI stock has decreased by 35.4% and is now trading at $1.04.
View the best growth stocks for 2025 here.

How were Organigram's earnings last quarter?

Organigram Holdings Inc. (NASDAQ:OGI) posted its quarterly earnings results on Tuesday, February, 11th. The company reported ($0.05) earnings per share for the quarter, missing analysts' consensus estimates of ($0.03) by $0.02. Organigram had a negative net margin of 31.69% and a negative trailing twelve-month return on equity of 8.59%.
Read the conference call transcript.

When did Organigram's stock split?

Organigram's stock reverse split before market open on Friday, July 7th 2023. The 1-4 reverse split was announced on Friday, July 7th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Friday, July 7th 2023. An investor that had 100 shares of stock prior to the reverse split would have 25 shares after the split.

How do I buy shares of Organigram?

Shares of OGI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Organigram own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Organigram investors own include i3 Verticals (IIIV), Ford Motor (F), Lucid Group (LCID), Trade Desk (TTD), Finance of America Companies (FOA), NVIDIA (NVDA) and

Company Calendar

• Last Earnings: 2/11/2025
• Today: 4/16/2025
• Next Earnings (Estimated): 5/13/2025
• Fiscal Year End: 9/30/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Pharmaceutical preparations
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:OGI
• CIK: 1620737
• Web: www.organigram.ca
• Phone: (844) 644-4726
• Fax: N/A
• Employees: 860
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($0.38)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-33,390,000.00
• Net Margins: -31.69%
• Pretax Margin: -31.53%
• Return on Equity: -8.59%
• Return on Assets: -6.54%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 3.36
• Quick Ratio: 1.85

Sales & Book Value

• Annual Sales: $166.12 million
• Price / Sales: 0.79
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $1.83 per share
• Price / Book: 0.57

Miscellaneous

• Outstanding Shares: 126,256,000
• Free Float: 126,103,000
• Market Cap: $131.31 million
• Optionable: Optionable
• Beta: 1.10